These findings corroborate recent studies that showed that pretreatment with CAT mitigated inflammatory actions in mice with chronic inflammatory skin disease, endometritis and cardiac inflammation via the inhibition of the NF-κB pathway [16,25]. This evidence concerns the gene NFKB1 and endometritis.